Wales's specialist non-surgical cancer centre, providing radiotherapy and systemic therapy for south-east Wales and hosting the Wales Cancer Research Centre.
Velindre Cancer Centre, part of Velindre University NHS Trust, has provided specialist cancer treatment in Cardiff since 1956 and is the tertiary radiotherapy and medical oncology centre for south-east Wales. With Cardiff University it hosts the Wales Cancer Research Centre and the Wales Cancer Trials Unit, which coordinates UK and international trials in lung, colorectal, prostate and rare cancers, and works with the Wales Research and Diagnostic PET Imaging Centre. A new Velindre Cancer Centre is being built to expand radiotherapy, stereotactic and clinical trials capacity. The trust also runs the Welsh Blood Service and supports outreach clinics across the region.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Velindre Cancer Centre, including child institutions. 91 works · 1,075 citations · 69% open access · 19% clinical trials · 1% reviews.
Chief executive of the Welsh health trust that runs Velindre Cancer Centre, the specialist cancer hospital for south east Wales.
Jacinta Abraham represents Velindre Cancer Centre in the Organisation of European Cancer Institutes, which lists the centre among its members in United Kingdom.
The oncologist who led COIN, which showed that adding cetuximab to first-line chemotherapy did not extend life even in RAS wild-type bowel cancer, and who ran the UK's molecularly stratified platform trial.
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), Prostate cancer.
Shares Cutaneous squamous cell carcinoma, Head and neck squamous cell carcinoma, Colorectal cancer, Non-small-cell lung cancer.
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares Brachytherapy, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Prostate cancer.
Shares Brachytherapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), Non-small-cell lung cancer.
Shares Brachytherapy, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.